https://www.patsnap.com/resources/blog/rd-blog/depth-filtration-continuous-clarification-patent-landscape/ · Patsnap · data cut-off 2026-07-31 · downloaded from the live page
Patent Landscape · Depth Filtration
Depth Filtration Continuous Clarification Patents: Who Holds the Estate
  • 90.2% concentration. The top 5 of 16 ranked assignees hold 92 of the 102 records in scope — a field dominated by a handful of filers rather than a fragmented one.
  • One assignee alone accounts for 62 records, more than the next four combined, so freedom-to-operate work has to start with that single portfolio before looking anywhere else.
  • Filing has cooled since the 2022 peak of 10, with 2021's 4 filings falling to 2 by 2024 (-50%) — the last three-year span with complete data.
Get a prior-art report on your approach
102
Published Records
90%
Top-5 Share of All Records
-50%
Filing Growth 2021→2024
EP
Leading Jurisdiction

Filing growth compares 2021 (4 records) with 2024 (2) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 102 records in scope (CR5), not by the ranked leaders only.

Published byPatsnap Research··7 min readSourced from Patsnap Eureka
Overview

What this landscape covers

This landscape tracks patent families combining depth filtration hardware — depth filters, surge vessels, flow-balancing and diversion-valve control — with continuous or semi-continuous clarification workflows in bioprocessing. The scope spans 102 published records filed between 2015 and the 2026 data cut-off, drawn from IPC classes covering separation processes, bioreactors and cell-culture harvesting. Publication lags filing by roughly 18 months, so the final one or two years in any trend chart will always look thinner than they eventually turn out to be.

The records cluster heavily around cell-culture harvest and clarification steps upstream of downstream purification, rather than around filter media chemistry itself. That skew shows up directly in the IPC composition: bioreactor and microorganism classes dominate, while classical separation-process classifications are a minority presence.

Filing activity and technology composition, 2015-2026
  1. 1AMGEN INC62
  2. 2REPLIGEN CORP13
  3. 3REGENERON PHARMACEUTICALS INC11
  4. 4ICHNOS SCIENCES SA4
  5. 5GRAVER CO2
  6. 6BRISTOL MYERS SQUIBB CO2
  7. 7MICROPORE TECH LTD2
  8. 8Ichnos Sciences SA1
  9. 9IGI THERAPEUTICS SA1
  10. 10REVALESIO CORP1
Source: Patsnap Eureka. Assignee ranking and totals. Derived from a Patsnap search on Depth Filtration Continuous Clarification covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
The data

Filing trend and technology mix

Two views of the same 102-record set: how filing activity has moved year over year, and which IPC subclasses the records sit in. Because a single record can carry several IPC codes, the subclass shares below add up to well over 100% of the record total — that is expected, not an error.

Filing trend, 2017-2026

Filings ran from 7 in 2017 up to a peak of 10 in 2022, then eased to 2 by 2024 — a -50% move from 2021's 4 filings. 2025 and 2026 are still filling in under the publication lag and should not be read as a drop-off yet.

Filing trend, 2017-202603581072017201820192020202110202220232024202502026Most recent year is partial — publication lag means later filings are not yet visible.

IPC subclass composition

C12M (bioreactors, 80.4% of records) and C12N (microorganisms, 79.4%) dominate, with C12P fermentation close behind at 71.6%. B01D — the separation-process class that names the filtration hardware directly — appears in only 25.5% of records, meaning most claims are framed around the bioprocess workflow rather than the filter media itself.

IPC subclass compositionC12M · Bioreactors & enzyme apparatus8280.4%C12N · Microorganisms & genetic engin…8179.4%C12P · Fermentation & enzymatic synth…7371.6%C07K · Peptides & proteins3231.4%B01D · Separation processes (filtrati…2625.5%A61M · Devices for body fluids65.9%F04B · Positive-displacement pumps32.9%A61K · Medicinal preparations22.0%Other1716.7%

Shares are the percentage of the 102 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.

Source: Patsnap Eureka. Filing trend and technology composition. Derived from a Patsnap search on Depth Filtration Continuous Clarification covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.

Go deeper on Depth Filtration Continuous Clarification with Eureka

This page is one run against one query. Ask Eureka your own question about depth filtration continuous clarification and every answer comes back with the patent numbers behind it.

Try Eureka
Key patents

The representative filing and what it blocks

Representative filing
WO2022221410A12022-10-20

WO2022221410A1 — Systems and methods for tangential flow depth filtration

REPLIGEN CORPORATION

The present disclosure relates to hollow fiber tangential flow filter units, including hollow fiber tangential flow depth filter units, for various applications, including bioprocessing and pharmaceutical applications, systems employing such filters, and methods of filtration using the same.Filed by Repligen, published 2022-10-20.

WO2022221410A1 — patent drawing 1WO2022221410A1 — patent drawing 2
View full filing
Most-cited records in this dataset
#Publication no.Patent titleCitations
1WO2015188009A1Methods for harvesting mammalian cell cultures45
2GB2385008ASurface Microfilter20
3GB2385008BSurface microfilters5
4US11339775B2Alternating tangential flow rapid harvesting4
5US11384378B2Methods for harvesting mammalian cell cultures4
6WO2015188009A9Methods for harvesting mammalian cell cultures4
7US20180148677A1Alternating Tangential Flow Rapid Harvesting3
8US20230332201A1Cell culture methods for antibody production1
9US20220356502A1Methods for harvesting mammalian cell cultures1
10WO2022221410A1Systems and methods for tangential flow depth filtration1

Citation counts favour older records simply because they have had more time to accumulate them — read this as a signal of influence within the corpus, not of current commercial importance.

Each row carries its publication number; clicking a row searches Eureka by that number.

Source: Patsnap Eureka. Citation counts and representative records. Derived from a Patsnap search on Depth Filtration Continuous Clarification covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Run it yourself

Put your own technology through the same analysis


  
Where to run it
Fastest

Eureka on the web

When you want the answer in the next five minutes.

The agent works the prompt against patents and technical literature, citing every source.

Run your analysis now →
For builders

MCP server & REST API

When it has to run inside your own pipeline.

Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.

Browse MCP servers →
Insights

What the numbers mean for strategy

Three findings that shape where to file, where to watch, and where a design-around is actually available.

Concentration
90.2%
of 102 records held by top 5

A one-company-dominant field

With a single assignee holding 62 of the 102 records and the top five holding 92, this is not a landscape where a new entrant can quietly file adjacent claims and expect white space by default. Any freedom-to-operate review has to clear the leading portfolio first.

Top 5 of 16 ranked assignees
Filing momentum
-50%
2021 to 2024 filings

Cooling after a 2022 peak

Filing activity peaked at 10 records in 2022 and had fallen to 2 by 2024, a -50% move over that span. Given the 18-month publication lag, 2025-2026 figures are not yet reliable evidence of a continued decline.

Peak year: 2022 at 10 filings
Claim framing
25.5%
of records in B01D (separation processes)

Bioprocess workflow, not filter media

Most records are classified under bioreactor and microorganism codes (C12M, C12N) rather than the separation-process class B01D. Claims are being written around the continuous-clarification workflow — surge vessels, flow balancing, valve switching — more than around depth-filter media composition itself.

C12M appears in 80.4% of records
Eureka AI Agent
Looking for what nobody has claimed yet?

Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to depth filtration continuous clarification, with the prior art for and against each one.

Find the white space →
Source: Patsnap Eureka. Co-assignee relationships and derived observations. Derived from a Patsnap search on Depth Filtration Continuous Clarification covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Players

Who is filing, and where the gaps sit

Sixteen assignees make up the entire ranked field returned by the data endpoint — this is not a top-50 or top-100 cut, it is the whole list. Momentum across the recent-year window has flattened for the named leaders, several showing 0 filings in the latest year.

Leader
62
records

A single dominant portfolio

One assignee holds 62 of the 102 records in scope, well ahead of the fifth-place holder at 2 records. Any competitive read of this space starts with that portfolio's claim scope, not with the long tail below it.

More than 60% of all records in scope
Long tail
16
ranked assignees

A sharp drop after the top five

The top 10 combined hold 97.1% of all 102 records, leaving only a handful of records spread across the remaining ranked entrants. New filers face a landscape where most adjacent claim space is already occupied by a small group.

Top 10 combined: 99 of 102 records
Momentum
0
latest-year filings for several leaders

Recent activity has flattened

Several of the leading assignees recorded zero filings in the latest year tracked, with year-over-year drops of -100% for at least two of them. That reads as filing quiet rather than retreat, given the publication lag on the most recent cohort.

Data cut-off 2026-07-31
🔍
Under-claimed branches worth checking before filing
Sub-areas where the IPC composition and citation pattern suggest claim density is thin relative to the core harvest-and-clarification cluster.
Filter-media regeneration cyclesPositive-displacement pump integration (F04B)Body-fluid-contact filtration devices (A61M)Automated diversion-valve control logicSurge-vessel sizing for variable-titre feeds
Rank all filers by momentum →
Recent-year filing momentum by assignee
AssigneeRecent yearYoY
Amgen Inc.0-100%
Repligen Corporation0
Regeneron Pharmaceuticals Inc.0-100%
IGI Therapeutics SA0
Bristol Myers Squibb Co.0
Graver Co.0
HOLDICH RICHARD G0
CUMMING IAIN W0
Source: Patsnap Eureka. Assignee-level momentum. Derived from a Patsnap search on Depth Filtration Continuous Clarification covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
What's next

Where to take this

The dataset points to specific next steps rather than general monitoring.

Clear the leading portfolio first

Before filing in continuous clarification, map the claim scope of the single assignee holding 62 of the 102 records — it sets the practical boundary for what remains open.

Run a freedom-to-operate check

Test the under-claimed branches

Positive-displacement pump integration and automated valve-control logic show thin claim density relative to the harvest-and-clarification core — worth a closer prior-art pull before drafting.

Explore white space in Eureka

Watch for the 2025-2026 catch-up

The last two years in the trend chart understate true filing activity because of publication lag; re-run this landscape in a year to see the corrected 2024-2025 picture.

Set a monitoring alert
Source: Patsnap Eureka. Forward-looking reading of the same dataset. Derived from a Patsnap search on Depth Filtration Continuous Clarification covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
FAQ

Common questions on this landscape

Answers are grounded in the same dataset. Derived from a Patsnap search on Depth Filtration Continuous Clarification covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Research Depth Filtration Continuous Clarification in depth with Eureka

Go past this page: query the whole depth filtration continuous clarification corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.

Try Eureka

Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.

Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.

Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.